Back to Market Feed

ZORYVE 0.3% FOAM

$15.3897per GM

High Outlier

Strength

3 mg/g

Manufacturer

Arcutis Biotherapeutics, Inc.

NDC

80610043060

Classification

Brand

Dosage Form

AEROSOL, FOAM

Route

TOPICAL

Last Updated

1/1/2026

Active Ingredients

Approval Type

New Drug (NDA)

FDA Application

On Market Since

12/15/2023

Pharmacological Classes

Phosphodiesterase 4 Inhibitor

Phosphodiesterase 4 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+4.0%

1Y

+4.0%

3Y

N/A

5Y

N/A

All

+12.2%

Generic Alternatives

Save up to 0%

1 alternative • Same active ingredient

ZORYVE 0.3% CREAM

80610013060•Arcutis Biotherapeutics, Inc.

Related Drugs

Same classification

EUCRISA 2% OINTMENT

55724021111•Pfizer Inc.

EUCRISA 2% OINTMENT

55724021121•Pfizer Inc.

OTEZLA 20 MG TABLET

55513049760•Amgen Inc.

OTEZLA 30 MG TABLET

55513013760•Amgen Inc.